With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeted Hyperactivation of PI3K/AKT in B-cell malignancies||Dana-Farber Cancer Institute / Vishal Khairnar, PhD||Young Investigator Grants||2019||Massachusetts|
|Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies||Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD||Young Investigator Grants||2021||Ohio|
|PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / Jessica Blackburn, PhD||Young Investigator Grants||2013||Massachusetts|
|WIP1 Modulates Responsiveness of MB to Genotoxic Stress.||Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta / Robert Craig Castellino, MD||Young Investigator Grants||2006||Georgia|
|A CRISPRi Genetic Screen in Ewing sarcoma Identifies a Novel Dependence on Homologous Recombination DNA Repair||University of California San Francisco / Asmin Tulpule, MD/PhD||Young Investigator Grants||2016||California|
|Micro-environmental Regulators of Ewing sarcoma Metastasis||University of Pittsburgh / Kelly Bailey, MD/PhD||Young Investigator Grants||2016||Pennsylvania|
|Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct||University of Wisconsin - Madison / Mario Otto||Young Investigator Grants||2012||Wisconsin|
|A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor||Dana-Farber Cancer Institute / Shuning He, PhD||Young Investigator Grants||2015||Massachusetts|
|Untangling the Matrix in Medulloblastoma||St. Christopher's Hospital for Children / Duncan Stearns, MD||Young Investigator Grants||2008||Ohio|
|MYC-driven Core Regulatory Circuits in Neuroblastoma||Dana-Farber Cancer Institute / Mark Zimmerman, PhD||Young Investigator Grants||2018||Massachusetts|